Results 161 to 170 of about 825,057 (283)

Thyroid-Stimulating Hormone Immunoassay Interference Presenting as Treatment-Refractory Hypothyroidism: A Case Report. [PDF]

Cureus
Al Ismaili H, Al Kiyumi M.
europepmc   +1 more source

Thyroid-Stimulating Hormone Levels and Depression in Older Adults: Cross-sectional and Longitudinal Analyses in a Community-Dwelling Population

Thyroid-Stimulating Hormone Levels and Depression in Older Adults: Cross-sectional and Longitudinal Analyses in a Community-Dwelling ...
Dr Mojtaba Lotfaliany (20885558), Robyn L Woods (13585534), Dr Malcolm Forbes (20885552), Duncan J Topliss (13599484), Mohammadreza Mohebbi (13085409), Dr Tayler Watson (20885555), John J McNeil (13407687), Michael Berk (13060851)   +7 more
core  

Endocrine therapy‐induced cancer‐related fatigue in hormone‐dependent malignancies: Mechanisms, impact, and management strategies

Precision Medical Sciences, EarlyView.
Multipathway schematic of endocrine therapy–induced cancer‐related fatigue. Endocrine interventions trigger four interacting mechanisms—neuroendocrine dysregulation, systemic inflammation, energy‐metabolic failure, and psycho‐behavioral amplification—that culminate in the multidimensional CRF phenotype.
Jiajing Jiang, Jun Lu, Sen Qin, Ruzhou Chen, Qiuchen Zhang, Lvqi He, Yubei Li, Jingyao Yan   +7 more
wiley   +1 more source

A Cross-Sectional Observational Study of Serum Thyroid-Stimulating Hormone (TSH) in Rheumatoid Arthritis Patients in a Tertiary Care Hospital. [PDF]

Cureus
Patel Y, Patel R, Patel YK.
europepmc   +1 more source

18F‑FAPI‑04 PET/CT imaging of fibroblast activating protein reveals myocardial injury beyond cancer staging

Precision Radiation Oncology, EarlyView.
Early detection of myocardial injury in cancer patients remains challenging with conventional diagnostic tools. 18F‐FAPI‐04 PET/CT revealed abnormal myocardial uptake associated with cardiovascular risk factors and biomarkers. 18F‐FAPI‐04 PET/CT enables early, noninvasive detection of myocardial injury, providing additional clinical value beyond cancer
Jing Jia, Chuan Zhou, Shuzhen Yi, Jinsong Zheng, Chengqiang Li, Jingjie Qin, Yuchun Wei   +6 more
wiley   +1 more source

Thyroid-stimulating hormone receptor mediates peripheral-central neuroimmune crosstalk in autoimmune thyroid diseases. [PDF]

BMC Med
Zhang H, Jiang S, Zhu T, Liu Y, Li J, Fang S, Li Y, Sun J, He X, Tong C, Gao Z, Fan X, Zhou H.   +12 more
europepmc   +1 more source

Herbal Therapeutics in Osteoporosis: Mechanisms, Evidence, and Translational Potential

Phytotherapy Research, EarlyView.
Schematic overview of bone remodeling dysregulation in osteoporosis and the multi‐target protective role of herbal therapeutics. ABSTRACT Osteoporosis is a chronic bone disease marked by reduced density and increased fracture risk. Current treatments face limitations in safety, efficacy, and long‐term adherence, prompting interest in alternative ...
Elnaz Vafadar Moradi, Sina Vossoughinia, Zahra Yazdanpanah, Hossein Sobhani, Jalileh Jalali, Mahboobeh Ghasemzadeh Rahbardar   +5 more
wiley   +1 more source

Cardiovascular Risk Assessment in Subclinical Hypothyroid Individuals with Thyroid-stimulating Hormone <10 uIU/ml. [PDF]

Indian J Endocrinol Metab
Mohanty SR, Agrawal NK, Ghosh S, Kumar R, Manisha M.   +4 more
europepmc   +1 more source

Intersection of systemic lupus erythematosus and autoimmune thyroid disease: Shared pathophysiology, epidemiology, diagnosis, and management

Rheumatology &Autoimmunity, EarlyView.
A proposed mechanistic framework of systemic lupus erythematosus (SLE) and autoimmune thyroid disease (AITD) pathogenesis. In Stage 1, genetically susceptible individuals harbor risk variants within major histocompatibility complex (HLA) and non‐HLA loci that impair central and peripheral immune tolerance mechanisms within the thymic and peripheral ...
Elisa Elisa, Awalia Awalia, Deasy Ardiany, Henry Sutanto   +3 more
wiley   +1 more source

Epigenetic Modulation of Thyroid-Stimulating Hormone Receptor Expression in Orbital Fibroblasts From Graves' Ophthalmopathy: Target for Treatment. [PDF]

Invest Ophthalmol Vis Sci
Chompoowong R, Phankeaw P, Suwannavong A, Visamol S, Pitikiadtikun S, Saonanon P, Pruksakorn V, Potita P, Palaga T, Virakul S.   +9 more
europepmc   +1 more source